Evolution of the Average Target: Leidos Holdings, Inc.

Evolution of the Target Price: Leidos Holdings, Inc.

Changes in Analyst Recommendations: Leidos Holdings, Inc.

3c2c08653.SOq6jsI7yCPbc-aetPDQbShuOweaQe-E6EUo7wXhQQw.Gbri64oWv2GIOrXE15mzXl4Ybm7LMa7AgjBOi1yQEUkJr9LMhEuOZKE9jQ~9ea6065bc726d2d3191a453d79df84a8
07-17 Wells Fargo Adjusts Leidos Price Target to $120 From $165, Maintains Equal Weight Rating MT
07-13 Goldman Sachs Adjusts Leidos Price Target to $152 From $171, Maintains Neutral Rating MT
07-13 JPMorgan Adjusts Price Target on Leidos to $160 From $210, Maintains Overweight Rating MT
07-13 Analyst recommendations: Biogen, Deckers Outdoor, Fortinet, Marathon Petroleum, UnitedHealth… Zonebourse
07-10 Baird Adjusts Price Target on Leidos to $125 From $195 MT
07-10 Truist Cuts Price Target on Leidos Holdings to $160 From $195, Keeps Buy Rating MT
07-10 Analyst recommendations: Cubesmart, Fox Corporation, AMD, Crowdstrike, Micron… Zonebourse
07-07 TD Cowen Adjusts Price Target on Leidos Holdings to $115 From $160 MT
07-07 Analyst recommendations: Ferguson, Medpace, Biogen, Crowdstrike, Take-Two… Zonebourse
07-01 Jefferies Adjusts Price Target on Leidos Holdings to $110 From $140, Keeps Hold Rating MT
07-01 Citigroup Adjusts Price Target on Leidos Holdings to $138 From $178, Maintains Buy Rating MT
06-30 UBS Adjusts Price Target on Leidos to $124 From $204, Maintains Neutral Rating MT
06-26 Argus Adjusts Price Target on Leidos Holdings to $180 From $225, Maintains Buy Rating MT
06-17 Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says MT
06-17 BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200 MT
06-17 BofA No Longer Rates Leidos a Buy, Shares Slide Zonebourse
06-17 BofA Downgrades Leidos Holdings to Neutral From Buy, Cuts Price Target to $125 From $200 MT
06-17 BofA Downgrades Leidos Holdings to Neutral From Buy, Price Target is $125 MT
06-03 Jefferies Downgrades Leidos to Hold From Buy, Adjusts Price Target to $140 From $185 MT
05-27 BNP Paribas Initiates Leidos Holdings at Outperform With $165 Price Target MT
05-11 Goldman Sachs Adjusts Price Target on Leidos Holdings to $171 From $180 MT
05-06 Leidos Stock Continues to Face Pressure Over Uncertainty of Health, Defense Portfolios, RBC Capital Markets Says MT
05-06 TD Cowen Adjusts Price Target on Leidos Holdings to $160 From $175 MT
04-20 Truist Lowers Price Target on Leidos Holdings to $195 From $220, Keeps Buy Rating MT
04-13 TD Cowen Adjusts Price Target on Leidos Holdings to $175 From $190, Maintains Hold Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+30.33%
+9.17%
+2.96%
+7.82%
+4.88%
+30.08%
+6.1%
+25.42%
+25.51%
-6.03%
Average +13.63%
Weighted average by Cap. +10.51%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
118.72USD
Average target price
150.67USD
Spread / Average Target
+26.91%
High Price Target
225.00USD
Spread / Highest target
+89.52%
Low Price Target
110.00USD
Spread / Lowest Target
-7.35%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wells Fargo Securities
Goldman Sachs
JPMorgan Chase
Baird
Truist Securities
TD Cowen
Jefferies & Co.
Citigroup
UBS
Argus
BofA Securities
BNP Paribas
RBC Capital Markets
Stifel Nicolaus
Morgan Stanley
Cantor Fitzgerald
William Blair & Co.
Melius Research
Barclays
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
118.72USD
Average target price
150.67USD
Spread / Average Target
+26.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LDOS Stock
  4. Consensus Leidos Holdings, Inc.